Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 30
Filtrar
1.
Urologe A ; 55(10): 1329-1334, 2016 Oct.
Artículo en Alemán | MEDLINE | ID: mdl-27246476

RESUMEN

BACKGROUND: The morphology of experimental precancerous lesions of the urinary bladder has been interpreted quite differently by various authors. OBJECTIVES: The aim of this investigation was to quantify these lesions by karyometry and, thus, to gain a more reliable understanding of the process. MATERIALS AND METHODS: A total of 60 Wistar rats were fed with N­butyl-N-(4-hydroxybutyl)nitrosamine (BBN) at a concentration of 0.05 % in their drinking water to induce preneoplastic changes of the urothelium. After the second week of BBN exposition, 6 animals were killed every 2 weeks up to week 20. Smears of the scraped off urothelium of 3 urinary bladders of each group were analyzed cytologically and karyometrically. RESULTS: BBN exposition led to statistically significant changes of the karyometric values using the χ2 test to differentiate the control animals from the ones that had ingested BBN and the 2­week groups from each other. These changes consisted mainly in significant deviations of the size of the nuclear area within the different groups. CONCLUSION: Morphological and karyometrical analysis showed that biologically relevant stages in the development of chemically induced urothelial precancerous lesions could be realized much earlier than had been assumed in recent publications. Karyometric analysis offered a valid basis to describe the early morphologic alterations of carcinogenesis.


Asunto(s)
Butilhidroxibutilnitrosamina , Modelos Animales de Enfermedad , Lesiones Precancerosas/inducido químicamente , Lesiones Precancerosas/patología , Neoplasias de la Vejiga Urinaria/inducido químicamente , Neoplasias de la Vejiga Urinaria/patología , Animales , Carcinógenos , Cariometría/métodos , Lesiones Precancerosas/genética , Ratas , Ratas Wistar , Reproducibilidad de los Resultados , Sensibilidad y Especificidad , Neoplasias de la Vejiga Urinaria/genética , Urotelio/efectos de los fármacos , Urotelio/patología
2.
Epidemiol Infect ; 138(9): 1289-91, 2010 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-20056016

RESUMEN

Schistosoma japonicum infection associated with a rectal carcinoid in an asymptomatic 44-year-old female from the Philippines is described. A systematic review of the literature could not identify similar reports, suggesting a rare coincidence. However, epidemiological data on the frequency of both conditions as well as published results of a colorectal screening programme from China indicate that underreporting of this concurrence is likely. Moreover, several studies suggest a causal link between schistosomiasis caused by S. japonicum and more common gastrointestinal malignancies such as colorectal carcinoma. Hence the presented case and the apparent neglect of this observation in the current literature allow speculation on a role of S. japonicum in the pathogenesis of rare gastrointestinal neoplasms such as carcinoid tumours as well. Future reports on similar observations could help to determine the need for systematic investigations and are strongly encouraged.


Asunto(s)
Tumor Carcinoide/parasitología , Neoplasias del Recto/parasitología , Esquistosomiasis Japónica/complicaciones , Adulto , Femenino , Humanos
3.
Dtsch Med Wochenschr ; 128(37): 1884-6, 2003 Sep 12.
Artículo en Alemán | MEDLINE | ID: mdl-12970822

RESUMEN

HISTORY: A 61-year-old woman was referred because of painless jaundice, laboratory tests having indicated hepatitis with impaired liver functions. For the past two years she had been taking phenprocoumon because she had atrial fibrillation. INVESTIGATIONS: Serological tests largely excluded infectious, autoimmune or metabolic etiology, so that the diagnosis of drug-induced hepatic disease was made. Liver biopsy showed necrotic liver cells and mild inflammatory reaction. TREATMENT AND COURSE: A perforating duodenal ulcer required urgent surgical intervention, after which liver functions further deteriorated. The patient having refused liver transplantation she was treated symptomatically (oral vitamin K. lactulose, diuretics), phenprocoumon was discontinued and her condition slowly improved. She was discharged after two months. At subsequent examination she was symptom-free, the INR was 1.41, transaminases were normal and ultrasound merely showed a slightly inhomogeneous internal structure. CONCLUSION: Phenprocoumon can cause liver damage even when the drug has been taken for prolonged periods without any problems. A careful history about previously administered drugs should be taken in any case of hepatitis of uncertain etiology.


Asunto(s)
Anticoagulantes/efectos adversos , Enfermedad Hepática Inducida por Sustancias y Drogas/diagnóstico , Fallo Hepático/inducido químicamente , Fenprocumón/efectos adversos , Anticoagulantes/uso terapéutico , Fibrilación Atrial/tratamiento farmacológico , Enfermedad Hepática Inducida por Sustancias y Drogas/etiología , Femenino , Humanos , Hígado/patología , Pruebas de Función Hepática , Persona de Mediana Edad , Fenprocumón/uso terapéutico
4.
Dtsch Med Wochenschr ; 124(36): 1029-32, 1999 Sep 10.
Artículo en Alemán | MEDLINE | ID: mdl-10506840

RESUMEN

HISTORY AND ADMISSION FINDINGS: A 28-year-old body builder was admitted because of jaundice. For 80 days, until 3 weeks before hospitalization, he had been taking moderately high doses of anabolic steroids: metandienone (methandienone), 10-50 mg daily by mouth, and stanozolol, 50 mg intramuscularly every other day. Physical examination was unremarkable except for yellow discoloration of the skin and sclerae. INVESTIGATIONS: Bilirubin concentration was raised to 4.5 mg/dl, cholestasis enzymes were normal, while transaminase activities were raised. Liver biopsy was compatible with cholestasis induced by anabolic steroids. TREATMENT AND COURSE: Although the steroids had been discontinued, the patient's general condition deteriorated over 7 weeks. Serum bilirubin rose up to a maximum of 77.9 mg/dl. In addition renal failure developed with a creatinine concentration of 4.2 mg/dl. The patient's state improved simultaneously with the administration of ursodeoxycholic acid and the biochemical values gradually reached normal levels after several weeks. CONCLUSION: Anabolic steroids can cause severe cholestasis and acute renal failure. In this case there was a notable temporal coincidence between the administration of ursodeoxycholic acid and the marked clinical improvement.


Asunto(s)
Lesión Renal Aguda/inducido químicamente , Anabolizantes/efectos adversos , Enfermedad Hepática Inducida por Sustancias y Drogas/etiología , Colestasis/inducido químicamente , Metandrostenolona/efectos adversos , Estanozolol/efectos adversos , Enfermedad Aguda , Lesión Renal Aguda/diagnóstico , Lesión Renal Aguda/metabolismo , Adulto , Anabolizantes/administración & dosificación , Biopsia con Aguja , Enfermedad Hepática Inducida por Sustancias y Drogas/diagnóstico , Enfermedad Hepática Inducida por Sustancias y Drogas/metabolismo , Colestasis/diagnóstico , Colestasis/metabolismo , Preparaciones de Acción Retardada , Humanos , Hígado/patología , Masculino , Metandrostenolona/administración & dosificación , Estanozolol/administración & dosificación
5.
Dtsch Med Wochenschr ; 124(34-35): 993-7, 1999 Aug 27.
Artículo en Alemán | MEDLINE | ID: mdl-10488326

RESUMEN

HISTORY AND ADMISSION FINDINGS: A multilocular superficial epithelial carcinoma (T1G3) and carcinoma in situ (Cis G3) of the bladder were resected transurethrally followed by intravesical instillation of BCG. The initial cycle of BCG administration had been free of complication, but then high fever, fatigue, cough and dyspnoea had developed with subsequent BCG maintenance treatment. Physical examination on admission revealed fever, clearly reduced general condition, and increased breath sounds with fine rales in the upper and middle lobes. INVESTIGATIONS: A clearly raised erythrocyte sedimentation rate (86 mm/h) and a CRP level at the upper limit of normal (13.6 mg/dl) indicated marked inflammatory reaction. The chest radiogram showed diffuse miliary opacities. Mycobacteria were not demonstrated in either gastric juice or bronchial secretion. TREATMENT AND COURSE: As BCG-induced miliary pneumonia was diagnosed, triple tuberculostatic treatment was commenced (ethambutol, 1200 mg/d; rifampicin, 600 mg/d; isoniazid, 300 mg/d). Nonetheless his condition deteriorated further. When prednisolone, 40 mg/d was added the symptoms improved rapidly. The tuberculostatic drugs were continued for 6 months. All symptoms had disappeared after 4 months. CONCLUSION: Miliary pneumonia is a rare complication of intravesical BCG installation of a superficial bladder cancer. As living bacteria cannot be excluded as the cause, triple tuberculostatic treatment must be started at once. If this fails to bring about improvement, additional steroid medication is recommended.


Asunto(s)
Vacuna BCG/efectos adversos , Carcinoma in Situ/complicaciones , Carcinoma de Células Transicionales/complicaciones , Neumonía Bacteriana/etiología , Cuidados Posoperatorios/efectos adversos , Tuberculosis Miliar/etiología , Tuberculosis Pulmonar/etiología , Neoplasias de la Vejiga Urinaria/complicaciones , Administración Intravesical , Anciano , Antituberculosos/uso terapéutico , Vacuna BCG/administración & dosificación , Carcinoma in Situ/terapia , Carcinoma de Células Transicionales/terapia , Terapia Combinada , Quimioterapia Combinada , Humanos , Masculino , Neumonía Bacteriana/diagnóstico , Neumonía Bacteriana/tratamiento farmacológico , Tuberculosis Miliar/diagnóstico , Tuberculosis Miliar/tratamiento farmacológico , Tuberculosis Pulmonar/diagnóstico , Tuberculosis Pulmonar/tratamiento farmacológico , Neoplasias de la Vejiga Urinaria/terapia
6.
Gastroenterology ; 117(4): 918-25, 1999 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-10500075

RESUMEN

BACKGROUND & AIMS: Ursodeoxycholic acid (UDCA) is used for treatment of primary biliary cirrhosis. Previous studies showed that, compared with UDCA monotherapy, bile salts plus prednisolone had no further effect on laboratory data but improved liver histology. Thirty percent of these patients had prednisolone-related side effects. Budesonide is a glucocorticoid with a high receptor affinity and a high first-pass metabolism. In this study we investigated whether budesonide and UDCA are superior to UDCA monotherapy. METHODS: A 2-year prospective, controlled double-blind trial was performed. Twenty patients (mainly with early-stage disease) were treated with UDCA at a dose of 10-15 mg/kg daily in addition to 3 mg budesonide 3 times daily (group A), and 19 patients (1 dropped out for personal reasons) were treated with UDCA plus placebo (group B). Liver biopsy specimens were taken before, after 12 months, and at the end of study. Glucose tolerance tests, serum cortisol levels, and adrenocorticotropin-stimulated cortisol secretion were assessed at regular intervals. Bone mass density was measured by dual-energy photon absorptiometry. RESULTS: Compared with pretreatment values, liver enzyme and immunoglobulin M and G levels decreased significantly in both groups. Improvement in group A was significantly more pronounced (P < 0.05) than in group B. Titers of antimitochondrial antibodies did not change. In group A, the point score of liver histology improved by 30.3%; in group B, it deteriorated by 3.5% (P < 0.001). Changes in bone mineral density after 2 years were -1.747% in group A and -0.983% in group B (P = 0.43). Budesonide had little influence on the hypothalamic-pituitary-adrenal axis. One patient in group A had budesonide-related side effects; in 3 patients in group B, complications of liver disease developed. CONCLUSIONS: Combination therapy with UDCA and budesonide is superior to UDCA and placebo.


Asunto(s)
Antiinflamatorios/uso terapéutico , Budesonida/uso terapéutico , Colagogos y Coleréticos/uso terapéutico , Cirrosis Hepática Biliar/tratamiento farmacológico , Ácido Ursodesoxicólico/uso terapéutico , Administración Oral , Administración Tópica , Antiinflamatorios/efectos adversos , Budesonida/efectos adversos , Colagogos y Coleréticos/efectos adversos , Método Doble Ciego , Quimioterapia Combinada , Femenino , Glucocorticoides , Humanos , Inmunoglobulina G/metabolismo , Inmunoglobulina M/metabolismo , Hígado/enzimología , Hígado/metabolismo , Hígado/patología , Cirrosis Hepática Biliar/metabolismo , Cirrosis Hepática Biliar/patología , Masculino , Persona de Mediana Edad , Estudios Prospectivos , Resultado del Tratamiento , Ácido Ursodesoxicólico/efectos adversos
7.
Dtsch Med Wochenschr ; 123(47): 1410-4, 1998 Nov 20.
Artículo en Alemán | MEDLINE | ID: mdl-9856112

RESUMEN

HISTORY AND CLINICAL FINDINGS: Two unrelated women, aged 39 and 42 years, had been admitted (at different times) to hospital because of "recurrence of an aetiologically uncertain acute hepatitis". Both patients had a history of acute hepatitis with GPT concentration of 796 and 755 U/l, respectively. Each of them had experienced recurrences of hepatitis, each of them preceded by taking herbal remedies as alternative medication, containing kava or common (or lesser) celandine, respectively. In each patient physical examination had been unremarkable. INVESTIGATIONS: Maximal values of GPT in the two patients were 422 and 350 U/l, respectively. Viral, autoimmune and metabolic causes of the hepatitis were excluded. In each of them liver biopsy revealed the picture of acute necrotizing hepatitis. DIAGNOSIS, TREATMENT AND COURSE: As it was suspected that the hepatitis was medication-induced, the intake of the mentioned herbal preparations was stopped. The liver function tests quickly became normal. CONCLUSION: In view of the rapid response to their withdrawal, a causal connection between intake of the herbal preparations and the recurrences of acute hepatitis is the most likely explanation in both cases.


Asunto(s)
Ansiolíticos/efectos adversos , Enfermedad Hepática Inducida por Sustancias y Drogas/etiología , Papaver/efectos adversos , Extractos Vegetales/efectos adversos , Plantas Medicinales , Enfermedad Aguda , Adulto , Alanina Transaminasa/sangre , Enfermedad Hepática Inducida por Sustancias y Drogas/patología , Femenino , Humanos , Kava , Necrosis , Recurrencia
8.
Cancer ; 59(3): 484-8, 1987 Feb 01.
Artículo en Inglés | MEDLINE | ID: mdl-3024805

RESUMEN

A neuroendocrine carcinoma of the thymus with an ectopic adrenocorticotropic hormone (ACTH) syndrome and melanocytic differentiation is described. ACTH, neuron-specific enolase (NSE) and S-100 protein were identified in the tumor by immunocytochemistry. Neurosecretory granules and melanosomes could be demonstrated in different cell populations by electronmicroscopy. The clinicopathologic findings are presented. The literature is briefly discussed.


Asunto(s)
Tumor Carcinoide/patología , Neoplasias del Timo/patología , Hormona Adrenocorticotrópica/biosíntesis , Tumor Carcinoide/fisiopatología , Diferenciación Celular , Proteínas del Citoesqueleto/análisis , Femenino , Hormonas Ectópicas/biosíntesis , Humanos , Melanocitos/patología , Persona de Mediana Edad , Fosfopiruvato Hidratasa/análisis , Proteínas S100/análisis , Neoplasias del Timo/fisiopatología
9.
Radiologe ; 26(1): 31-4, 1986 Jan.
Artículo en Alemán | MEDLINE | ID: mdl-2419944

RESUMEN

The case of a 48 years old man with intestinal lipodystrophy (Whipple's disease) is clinically, roentgenologically, endoscopically and histologically documented. The diagnosis was established by endoscopic biopsy and laparatomy. The patho-histologic changes of the mucosa of the proximal small bowel are pathognomonic. Roentgenologically the characteristic mucosal and lymphadenoid changes can be demonstrated as well as the extent of the process.


Asunto(s)
Enfermedad de Whipple/diagnóstico , Endoscopía , Humanos , Intestino Delgado/patología , Ganglios Linfáticos/patología , Masculino , Persona de Mediana Edad , Tomografía Computarizada por Rayos X , Enfermedad de Whipple/diagnóstico por imagen , Enfermedad de Whipple/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA